Source: International Congress 2015 – Sarcoidosis: clinical
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shruthi Konda (London, United Kingdom), Shruthi Konda, Felix Chua, Magdi Saba, Ranjit Pagonda, Raminder Aul. Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis. Eur Respir J 2015; 46: Suppl. 59, 845

Member's Comments

No comment yet.

Related content which might interest you: Are there any predictors of MTX response in progressive pulmonary sarcoidosis? Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Evaluation of ventricular arrhythmogenesis in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Prevalence of atrial fibrillation in patients with sarcoidosis Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Right ventricular strain differences between idiopathic and systemic sclerosis Pulmonary Hypertension Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension Year: 2017 Treatment and management of cardiac sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Negative outcome of prednisone in possible idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF clinical Year: 2016 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Management of cardiac sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Pulse therapy of corticosteroids in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab Source: International Congress 2016 – Sarcoidosis Year: 2016 Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006 Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Steroid treatment effect in pulmonary sarcoidosis (STEPS study) Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020